BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30278937)

  • 21. Neoadjuvant treatment improves capsular integrity and the width of the fibrous capsule of high-grade soft-tissue sarcomas.
    Grabellus F; Podleska LE; Sheu SY; Bauer S; Pöttgen C; Kloeters C; Hoiczyk M; Lauenstein TC; Schmid KW; Taeger G
    Eur J Surg Oncol; 2013 Jan; 39(1):61-7. PubMed ID: 23103117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series.
    Shewale JB; Mitchell KG; Nelson DB; Conley AP; Rice DC; Antonoff MB; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Mehran RJ; Vaporciyan AA; Weissferdt A; Sepesi B
    J Surg Oncol; 2018 Sep; 118(3):518-524. PubMed ID: 30109699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soft tissue sarcomas of the chest wall. Results of surgical resection.
    Gordon MS; Hajdu SI; Bains MS; Burt ME
    J Thorac Cardiovasc Surg; 1991 May; 101(5):843-54. PubMed ID: 2023441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
    Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
    Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma.
    Gannon NP; Stemm MH; King DM; Bedi M
    J Cancer Res Clin Oncol; 2019 May; 145(5):1321-1330. PubMed ID: 30847552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
    Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysis.
    Canter RJ; Qin LX; Downey RJ; Brennan MF; Singer S; Maki RG
    Cancer; 2007 Nov; 110(9):2050-60. PubMed ID: 17828771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating soft tissue sarcomas with adjuvant chemotherapy.
    Patrikidou A; Domont J; Cioffi A; Le Cesne A
    Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Lindner LH; Litière S; Sleijfer S; Benson C; Italiano A; Kasper B; Messiou C; Gelderblom H; Wardelmann E; Le Cesne A; Blay JY; Marreaud S; Hindi N; Desar IME; Gronchi A; van der Graaf WTA
    Int J Cancer; 2018 Jun; 142(12):2610-2620. PubMed ID: 29383713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of postoperative radiation on survival for high-grade soft tissue sarcoma of the extremities after limb sparing radical resection.
    Schreiber D; Rineer J; Katsoulakis E; Sroufe RL; Lange CS; Nwokedi E; Schwartz D; Choi K; Rotman M
    Am J Clin Oncol; 2012 Feb; 35(1):13-7. PubMed ID: 21278563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.
    Stahl JM; Corso CD; Park HS; An Y; Rutter CE; Han D; Roberts KB
    Eur J Surg Oncol; 2017 Jan; 43(1):168-174. PubMed ID: 27335080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
    Gronchi A; Palmerini E; Quagliuolo V; Martin Broto J; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz Beveridge R; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Braglia L; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    J Clin Oncol; 2020 Jul; 38(19):2178-2186. PubMed ID: 32421444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.
    Davis EJ; Zhao L; Lucas DR; Schuetze SM; Baker LH; Zalupski MM; Thomas D; Chugh R
    BMC Cancer; 2016 Aug; 16():663. PubMed ID: 27544129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery.
    Zhao RP; Yu XL; Zhang Z; Jia LJ; Feng Y; Yang ZZ; Chen XX; Wang J; Ma SL; Guo XM
    Radiat Oncol; 2016 Feb; 11():25. PubMed ID: 26911328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
    Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
    Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
    Coindre JM; Terrier P; Bui NB; Bonichon F; Collin F; Le Doussal V; Mandard AM; Vilain MO; Jacquemier J; Duplay H; Sastre X; Barlier C; Henry-Amar M; Macé-Lesech J; Contesso G
    J Clin Oncol; 1996 Mar; 14(3):869-77. PubMed ID: 8622035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: A multi-institutional propensity score analysis from the US Sarcoma Collaborative.
    Zaidi MY; Ethun CG; Liu Y; Poultsides G; Howard JH; Mogal H; Tseng J; Votanopoulos K; Fields RC; Cardona K
    J Surg Oncol; 2019 Sep; 120(3):332-339. PubMed ID: 31172536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
    Young RJ; Litière S; Lia M; Hogendoorn PCW; Fisher C; Mechtersheimer G; Daugaard S; Sciot R; Collin F; Messiou C; Grünwald V; Gronchi A; van der Graaf W; Wardelmann E; Judson I
    Acta Oncol; 2017 Jul; 56(7):1013-1020. PubMed ID: 28431480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Older age impacts radiotherapy-related outcomes in soft tissue sarcoma.
    Yuen NK; Li CS; Monjazeb AM; Borys D; Bold RJ; Canter RJ
    J Surg Res; 2015 Dec; 199(2):494-504. PubMed ID: 26163324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables.
    Stojadinovic A; Leung DH; Allen P; Lewis JJ; Jaques DP; Brennan MF
    J Clin Oncol; 2002 Nov; 20(21):4344-52. PubMed ID: 12409334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.